FBXW7-AS1 and COVID-19: The goals of this study were to characterize the expression of DEspR in subpopulations of immune cells in patients with COVID-19 and healthy donors and to determine the associations between the number of immune cells expressing a high level of DEspR (DEspRhigh), inflammatory factors, and the severity and clinical features of COVID-19.